Ruminant BioTech Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$9.6M
- Investors
-
11
Ruminant BioTech General Information
Description
Developer of a slow-release device designed for long-term controlled-release methane mitigation. The company's device contains a naturally occurring organic compound to deliver high levels of methane knockdown over that time period, enabling farmers to reduce greenhouse gas emissions.
Contact Information
Website
www.ruminantbiotech.comCorporate Office
- 24 Balfour Road, Parnell
- Future House
- Auckland, North Island
- New Zealand
Corporate Office
- 24 Balfour Road, Parnell
- Future House
- Auckland, North Island
- New Zealand
Ruminant BioTech Timeline
Ruminant BioTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 25-Nov-2025 | $9.6M | Completed | Generating Revenue | ||
| 3. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 2. Early Stage VC | 06-Apr-2023 | $7.58M | $7.58M | Completed | Generating Revenue | |
| 1. Grant | 30-Nov-2022 | $7.8M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ruminant BioTech Patents
Ruminant BioTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026906714-A0 | Boluses for administering a methane-inhibiting agent to a ruminant animal | Pending | 31-Jul-2026 | ||
| AU-2025904766-A0 | Bolus dosage form | Pending | 10-Oct-2025 | ||
| AU-2024903288-A0 | Gastric residence device | Inactive | 11-Oct-2024 | ||
| WO-2026079981-A1 | Gastric residence device | Pending | 11-Oct-2024 | ||
| CA-239354-S | Gastric residence device for animals | Active | 11-Oct-2024 |
Ruminant BioTech Signals
Ruminant BioTech Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cultivate Ventures | Venture Capital | Minority | ||
| Marex Group | Corporation | Minority | ||
| Rosrain Investments | Venture Capital | Minority | ||
| Agmardt | Not-For-Profit Venture Capital | Minority | ||
| AgResearch(New Zealand) | Government | Minority |
Ruminant BioTech FAQs
-
When was Ruminant BioTech founded?
Ruminant BioTech was founded in 2021.
-
Where is Ruminant BioTech headquartered?
Ruminant BioTech is headquartered in Auckland, New Zealand.
-
What is the size of Ruminant BioTech?
Ruminant BioTech has 21 total employees.
-
What industry is Ruminant BioTech in?
Ruminant BioTech’s primary industry is Other Agriculture.
-
Is Ruminant BioTech a private or public company?
Ruminant BioTech is a Private company.
-
What is the current valuation of Ruminant BioTech?
The current valuation of Ruminant BioTech is .
-
What is Ruminant BioTech’s current revenue?
The current revenue for Ruminant BioTech is .
-
How much funding has Ruminant BioTech raised over time?
Ruminant BioTech has raised $17.2M.
-
Who are Ruminant BioTech’s investors?
Cultivate Ventures, Marex Group, Rosrain Investments, Agmardt, and AgResearch(New Zealand) are 5 of 11 investors who have invested in Ruminant BioTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process